SYRE
Spyre Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SYRE fundamentals
Spyre Therapeutics (SYRE) released its earnings on Aug 5, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.49 (YoY +43.02%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.49
+43.02%
Report date
Aug 5, 2025
Earnings Call
7:00 AM on Aug 5, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Spyre Therapeutics (SYRE) key financial stats and ratios, covering profitability, financial health, and leverage.
Spyre Therapeutics (SYRE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Spyre Therapeutics (SYRE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Spyre Therapeutics (SYRE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Spyre Therapeutics (SYRE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Spyre Therapeutics (SYRE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Spyre Therapeutics's revenue and profit?What were the key takeaways from Spyre Therapeutics's earnings call?What is Spyre Therapeutics's latest dividend and current dividend yield?What is Spyre Therapeutics's gross profit margin?What is the market's earnings forecast for Spyre Therapeutics next quarter?What does Spyre Therapeutics do and what are its main business segments?Did Spyre Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Spyre Therapeutics’s earnings call?
